ACA
Arcosa, Inc. Common Stock
FABRICATED STRUCTURAL METAL PRODUCTS
Arcosa (ACA) Stock: Buy, Sell, or Hold?
$149.15
+0.12 (+0.08%)
▲
5d:
+1.46%
30d:
+1.81%
90d:
+2.86%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (46%)
Quality Score
62/100
Position
EXTENDED
30-Day Fair Range
$146.48 – $148.09
Position: EXTENDED
Forward P/E & Valuation
29.1x
STRETCHED
vs 25.1x historical avg
Wall Street Target
$146.67
-1.7% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$146.37 / $149.21
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: ACA trades at premium valuation expecting 5.1% growth. Hold existing positions but don't chase. Wait for better entry.
Get Alerted When ACA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$220.75
Based on 11.7% avg growth
INTRINSIC VALUE TODAY
$137.07
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ACA is currently trading at $149.15, which is considered extended relative to its 30-day fair value range of $146.48 to $148.09. From a valuation perspective, the stock is trading at a premium (Forward PE: 29.1) compared to its historical average (25.1). At these levels, the market is pricing in 5.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ACA is in a uptrend. The price is currently testing key support at $146.37. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ACA is in a uptrend. The price is currently testing key support at $146.37. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$146.48 -
$148.09
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
46.2%
Trading Range & Key Levels
30-Day Trading Range
$146.48 -
$148.09
Current vs Trading Range
EXTENDED
Support Level
$146.37
Resistance Level
$149.21
Current Trend
Uptrend
Technical data as of
Oct 22, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (57/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($146.67)
- NEUTRAL: PE elevated vs history but 5.1% growth expectation is conservative given 449% recent growth
- NEUTRAL: Bottoming setup forming (57/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
29.13
Wall Street Target
$146.67
(-1.7%)
Revenue Growth (YoY)
1.7%
Earnings Growth (YoY)
448.6%
Profit Margin
16.8%
Valuation Premium vs History
+5.1% premium
PE vs Historical
29.1 vs 25.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.1%
(market-implied from PE analysis)
1-Year Target
$156.76
(+5%)
2-Year Target
$164.75
(+11%)
3-Year Target
$173.15
(+16%)
3-Yr Target (if PE normalizes)
(PE: 29→25)
PE COMPRESSION
$149.18
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 29.1, Growth: 19.3%)
$253.17
(+70%)
Base:
(SPY PE: 19.9, Growth: 19.3%)
$172.58
(+16%)
Bear:
(PE: 16.9, Growth: 19.3%)
$146.70
(-2%)
Share ACA Analysis
Share this live ACA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ACA)
Bullish
7 Retail Mentions
Reddit / WSB Comments
6
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 7, 2026
Daily AI digest
AI Retail Discussion Summary:
One bullish StockTwits message expresses optimism towards $ACA.
Key Retail Themes:
Buy interest in $ACA
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:45 PM ET
Data refreshes hourly during market hours. Next update: 9:45 PM
Data refreshes hourly during market hours. Next update: 9:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Engineering & Construction Stocks
Top-rated stocks in Engineering & Construction by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PWR
Quanta Services Inc |
STRONG BUY
30 analysts |
$770 | 55 HOLD |
|
MTZ
MasTec Inc |
STRONG BUY
21 analysts |
$316 | 47 HOLD |
|
LGN
Legence Corp. Class A Co… |
STRONG BUY
17 analysts |
$94 | 49 HOLD |
|
DY
Dycom Industries Inc |
STRONG BUY
12 analysts |
$513 | 60 BUY |
|
STN
Stantec Inc |
STRONG BUY
11 analysts |
$94 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ACA Research Pages
